Revive Pharmaceuticals Private Limited
About Revive Pharmaceuticals Private Limited
Data last updated:
Revive Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1996PTC096954.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹24.07 Lakh. It was formerly known as Revive Pharmaceuticals Limited. It is led by directors Mahendra Kumar Kumawat and Madhusudan Govindprasad Ruia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 38 Nandjyot Indl Estatekurla Andheri Rd Safed Pool, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.11 Lakh, a growth of 81% compared to the previous year. For the same year it recorded a net profit of ₹17.72 Lakh (net margin 76.7%) and EBITDA of ₹22.86 Lakh (EBITDA margin 98.9%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹65.69 Cr and satisfied charges of ₹136.81 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Revive Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 38 Nandjyot Indl Estatekurla Andheri Rd Safed Pool, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Revive Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Revive Pharmaceuticals Private Limited
FY 2025 filings availableRevive Pharmaceuticals Private Limited reported revenue of ₹23.11 Lakh (up 81% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 81% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 98.9% | ||||
| Net Profit Margin | 76.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Revive Pharmaceuticals Private Limited, buy the company report.
Board of directors of Revive Pharmaceuticals Private Limited
Revive Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Kumar Kumawat | Director | 17 Sep 2020 | 6 Years 1 Months | Current |
| Madhusudan Govindprasad Ruia | Director | 06 Feb 2004 | 22 Years 8 Months | Current |
Peer comparison
Revive Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Philbert Pharmaceuticals Private Limited | ₹23.16 Lakh (FY 2025) | -9.0% | Surat, Gujarat, India | |||
| Moxie Pharmaceutical Private Limited | ₹23.15 Lakh (FY 2023) | -62.0% | Bhubaneswar, Odisha, India | |||
| Grassindia Pharmaceuticals Private Limited | ₹23.14 Lakh (FY 2025) | -96.0% | Aurangabad, Maharashtra, India | |||
| Nature Biochem Private Limited | ₹23.13 Lakh (FY 2024) | -39.0% | Bangalore, Karnataka, India | |||
| DNC Pharma Private Limited | ₹23.13 Lakh (FY 2025) | 8.0% | Moraiya, Gujarat, India | |||
| Revive Pharmaceuticals Private Limitedthis company | ₹23.11 Lakh (FY 2025) | ₹17.72 Lakh | 76.7% | 81.0% | Mumbai, Maharashtra, India | |
| Airmed Pharmaceuticals (India) Private Limited | ₹23.09 Lakh (FY 2020) | -47.0% | Hyderabad, Telangana, India | |||
| Abhyora Pharmachem Private Limited | ₹23.08 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Boldkingsvorld Pharmaceuticals Private Limited | ₹23.06 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Albatross Healthcare Private Limited | ₹23.01 Lakh (FY 2024) | 55.0% | Patna, Bihar, India | |||
| Marriop Pharmaceuticals Private Limited | ₹23.01 Lakh (FY 2025) | 8.0% | New Delhi, Delhi, India |
To see the full peer comparison of Revive Pharmaceuticals Private Limited, buy the company report.
Auditor
Revive Pharmaceuticals Private Limited is audited by KanodiaSanyal&Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KanodiaSanyal&Associates | FY 2023 | 008396N |
Shareholding
The shareholding of Revive Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Revive Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2024 | 100956463 | Sbicap Trustee Company Limited | ₹65.69 Cr | Open | |
| 06 Apr 2022 | 100559885 | Others | ₹3.08 Cr | Satisfied | |
| 23 Jun 2021 | 100457277 | Others | ₹5.68 Cr | Satisfied | |
| 25 Jul 2012 | 10368912 | Others | ₹36 Cr | Satisfied | |
| 23 Mar 2011 | 10284375 | Others | ₹36.7 Cr | Satisfied |
To see the full charge records of Revive Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Revive Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revive Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Revive Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Revive Pharmaceuticals Private Limited has 6 board changes on record since 2004: 2 appointments and 4 cessations. The latest: Mahendra Kumar Kumawat ceased to be Additional Director on 30 Nov 2021.
11 earlier events are in the company report.
Frequently asked questions
Revive Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 February 1996 (30+ years old) and is registered under CIN U24230MH1996PTC096954.
Revive Pharmaceuticals has 2 current directors:
- Mahendra Kumar Kumawat - Director
- Madhusudan Govindprasad Ruia - Director
The latest financial statements of Revive Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Revive Pharmaceuticals is U24230MH1996PTC096954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revive Pharmaceuticals was incorporated on 06 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Revive Pharmaceuticals by revenue are Philbert Pharmaceuticals Private Limited, Moxie Pharmaceutical Private Limited, Grassindia Pharmaceuticals Private Limited, Nature Biochem Private Limited, DNC Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Mahendra Kumar Kumawat ceased to be Additional Director on 30 Nov 2021. Mahendra Kumar Kumawat was appointed as Director on 17 Sep 2020. Sunil Rajaram Rane ceased to be Director on 17 Sep 2020. Revive Pharmaceuticals has 6 board changes on record in total.
The registered office of Revive Pharmaceuticals is at A – 38 Nandjyot Indl Estatekurla Andheri Rd Safed Pool, Mumbai, Maharashtra, India – 400072.
Revive Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Revive Pharmaceuticals has open charges of ₹65.69 Cr and satisfied charges of ₹136.81 Cr as per latest MCA filings.
The compliance status of Revive Pharmaceuticals is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.